
- Volume 0 0
Melatonin's Effectiveness Remains Murky
New evidence released by the Agencyfor Healthcare Research and Quality(AHRQ) concluded that melatonin does notwork in treating a majority of primary sleepdisorders.
The federal agency said that melatoninsupplements do not appear to affect sleepquality, wakefulness after sleep onset, totalsleep time, or percentage of the time spentin rapid eye movement sleep. All are key criteriafor an effective treatment for sleepproblems such as insomnia.
AHRQ's review suggested that melatoninin oral doses are relatively safe when takenfor the short term, over a period of days orweeks, and is safe at relatively high dosesand in various formulations. The agency,however, said the safety of melatonin supplementationwhen used for the long termremains unclear.
Articles in this issue
over 20 years ago
Issues in the Treatment of Patients with Hypothyroidismover 20 years ago
Health Organizations Favor Electronic Health Recordsover 20 years ago
Therapeutic Management of Bronchitisover 20 years ago
Program Advocates for Timely Prescription Refillsover 20 years ago
Cardinal Backs RFID Technologyover 20 years ago
Agreement Improves Point of Careover 20 years ago
Decision Unpopular with Health Care Professionalsover 20 years ago
The Importance of the Order of Drug Administrationover 20 years ago
Beware of Erroneous Daily Oral Methotrexate Dosing!Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.